Rio de La Plata study: A multicenter, cross-sectional study on cardiovascular risk factors and heart failure prevalence in peritoneal dialysis patients in Argentina and Uruguay

Kidney International

Volumn 73, Issue SUPPL. 108, 2008, Pages

  Moretta, G ^a,l   Locatelli, A J ^b   Gadola, L ^c   De Arteaga, J ^d   Sola L ^e   Caporale, N ^f   Schargorodsky, J ^g   Ducasse, E ^h   Pastorino, G ⁱ   Marchetta, N ^j   Espeche, W ^k   Ortiz, Z ^l  

^a Centro Nefrológico Azul   (Argentina)

^b Nefronosa SA   (Argentina)

^c UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^d HOSPITAL PRIVADO   (Argentina)

^e HOSPITAL MACIEL   (Uruguay)

^f Hospital Evangelico   (Uruguay)

^g Serv Terapia Renal Hurlingham SRL   (Argentina)

^h Centro de Enfermedades Renales   (Argentina)

ⁱ Hospital Transito Caceres de Allende Cordoba   (Argentina)

^j Rennius SA   (Argentina)

^k Instituto de Enfermedades Renales   (Argentina)

^l ACADEMIA NACIONAL DE MEDICINA   (Argentina)

more..

Author keywords

Cardiovascular risk factor; Heart failure; Left ventricular dysfuction; Peritoneal dialysis

Indexed keywords

CALCIUM PHOSPHATE; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ARGENTINA; ARTICLE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE CONDUCTION; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; SITTING; URUGUAY; VALVULAR HEART DISEASE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; ECHOGRAPHY; KIDNEY DISEASE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; RISK FACTOR;

ADULT; ARGENTINA; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERITONEAL DIALYSIS; PREVALENCE; RISK FACTORS; URUGUAY;

EID: 44449163631     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002618     Document Type: Article

References (40)

1. Foley RN, Parfrey PS, Sarnak MJ. Cardiovascular disease in chronic renal disease: clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(Suppl 3): S112-S119.
2. Joki N, Hase H, Nakamura R et al. Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 1997; 12: 718-723.
3. Goicoechea MÁ. Enfermedad cardiovascular en pacientes con estadios 4 y 5 de enfermedad renal cró nica. Pacientes en diá lisis cró nica Guìas SEN. Nefrología 2004; 24(Suppl 6): 161-171.
4. McMurray JV, McDonagh TA, Davie AP et al. Should we screen for asymtomatic left ventricular dysfunction to prevent heart failure? Eur Heart J 1998; 19: 842-846.
5. Parfrey PS, Foley RN, Harnett JD et al. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996; 11: 1277-1285.
6. Zoccali C, Benedetto F, Mallamaci F et al. Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol 2000; 15: 1029-1037.
7. Wang AY, Wang M, Woo J et al. A novel association between the degree of residual renal function and severrity of left ventricular hypertrophy in end stage renal failure patients undergoing long term peritoneal dialysis. Kidney Int 2002; 62: 639-647.
8. Jaar BG, Coresh J, Plantinga LC et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med 2005; 143: 173-184.
9. United States Renal Data System, USRDS 2006 Annual Data Report. National institutes of health, national institute of diabetes and digestive and kidney diseases. April 2006. Available at www.usrds.org, accessed 03/21/07.
10. Alonso Pulpon L. La epidemia de insuficiencia cardíaca. Son todos los que están y están todos los que son? Rev Esp Cardiol 2002; 55: 211-214.
11. Harris MI, Flegal KM, Cowie CC et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The third national health and nutrition examination survey, 1998-1994. Diabetes Care 1998; 21: 518-524.
12. Hernández RE, Cardonet LJ, Libman C et al. Prevalence of diabetes in an urban population of Argentina. Diabetes 1984; 81: 18-20.
13. West KJ, Kalbfleisch JM. Glucose tolerance nutrition and diabetes in Uruguay, Venezuela, Malasya and East Pakistan. Diabetes 1966; 15: 9-18.
14. Registro de la Sociedad Latinoamericana de Nefrología. Informe año 2001. Available at www.registroslanh.org.uy.
15. Sistema Nacional de Informació n. Registro Nacional de Insuficiencia Renal Cró nica Argentina. Reporte anual 2006, Buenos Aires. Available at www.sintra.incucai.gov.ar, accessed 03/27/07.
16. Foley RN, Herzog CA, Collins AJ. Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study. Kidney Int 2003; 63: 1462-1467.
17. Ho KK, Pinsky JL, Kannel WB et al. Epidemiology of heart failure: the framinghan study. Am Heart J 1991; 121(3 Part 1): 951-957.
18. Banegas JR, Rodriguez-Artalejo F, Guallar-Castillon P. epidemioló gica de la insuficiencia cardíaca en españa. Rev Esp Cardiol 2006; 6(Suppl): 4C-9C.
19. Mc Murray JJV, Pfeffer MA. Heart failure. Lancet 2005; 365: 1877-1889.
20. Parfrey P, Foley R. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999; 10: 1606-1615.
21. Wang AVN, Sanderson JE, Chan KW. Epidemiology of cardiovascular problems in Chinese continuous ambulatory peritoneal dialysis patients: prevalence, severity and risk factors. Hong Kong Med J 2007; 13: 33-36.
22. Teicholz LE, Kreulen T, Herman MW et al. Problems in echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976; 37: 7-11.
23. Zoccali C, Benedetto F, Mallamaci F et al. Left ventricular function monitoring in asymptomatic patients: a prospective cohort study. J Am Soc Nephrol 2006; 17: 1460-1465.
24. USRDS 1999 Annual Data Report Treatment Modalities for ESRD Patients Chapter III. Publishers.
25. Treatment of End-Stage Organ Failure in Canada 1995-2004. Annual Report 2006: 3-35.
26. Italian Registry of dialysis and transplantation (RIDT). 2004 update status in regional registries. 2006.
27. Wang TJ, Levy D, Benjamin EJ et al. The epidemiology of asymtomatic left ventricular systolic dysfunction, implications for screening. Ann Intern Med 2003; 138: 907-916.
28. McKee PA, Castelli WP, McNamara PM et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285: 1441-1446.
29. Gilbert R, Connelly K, Kelly D et al. Heart failure and nephropathy: catastrophic and interrelated complications of diabetes. Clin J Am Soc Nephrol 2006; 17: 193-208.
30. Foley RN, Culleton BF, Parfey PS. Cardiac disease in diabetic end state renal disease. Diabetologia 2002; 40: 1307-1312.
31. Foley RN, Parfrey PS, Harnett JD et al. Hypoalbuminemia, cardiac morbidity, and mortality in endstage renal disease. J Am Soc Nephrol 1996; 7: 728-736.
32. Qureshi AR, Alvestrand A, Divino-Filho JC et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002; 13: S28-S36.
33. Wang AY, Wang M, Woo J et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 2004; 15: 2186-2194.
34. Silberberg JS, Barre P, Prichard S et al. Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal failure. Am J Cardiol 1989; 64: 222-224.
35. González C, Solá L, Schwedt E et al. Registro Uruguayo de Diá lisis. Informe Año 2004.2da. Parte: Hemodiá lisis. Revista de Nefrología, Diálisis y Trasplante 2006; 26: 155-168.
36. Young EW, Akiba T, Albert JM et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 2004; 44(Suppl 2): 34-38.
37. Instituto Nacional de Estadisticas y Censos (INDEC). Encuesta permanente de hogares. Indicadores socioeconomicos 2006. Available at www.indec.mecon.ar, accessed 03/27/07.
38. Instituto Nacional de Estadisticas de Uruguay. Estimaciones de pobreza. Available at www.ine.gub.uy.
39. The 7th Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. US Department of health and human services, national institutes of health, national heart, lung, and blood institute. National High Blood Pressure Education Program. NIH Publication No. 04-5230 2004, pp 11.
40. Gottdiener J, Bednarz J, Devereux R et al. A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Echocardiography in clinical trials. J Am Soc Echocardiogr 2004; 17: 10, 1088-1098.